Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partnership with leading Ad-tech tech provider

30 Sep 2020 08:30

RNS Number : 4966A
Iconic Labs PLC
30 September 2020
 

 

 

 

 

Iconic Labs Plc ("Iconic Labs" or the "Company")

 

Partnership with leading Ad-tech tech provider

 

Iconic Labs Plc (LSE:ICON), a multidivisional new media and technology business, today announces that after a successful trial Iconic Labs has signed a commercial partnership agreement with Glimpse Protocol, a leading provider of advanced technologies to Ad-tech.

This partnership will allow Iconic Labs to be well positioned to become industry leaders in the cookieless advertising space and future proof this part of the Company's business. Glimpse Protocol will benefit from Iconic Labs advertising experience and access to multiple platforms, including to trial their technology.

Glimpse Protocol will compete for programmatic inventory on the Iconic Labs platforms with other advertisers and will not receive any discount to market rate. This offering will allow programmatic advertisers to comply with GDPR and internal policies while still conducting effective advertising.

Iconic Labs will use the Glimpse Protocol's technology on all of their owned and operated platforms including JOE Media where the Glimpse Protocol platform will be tested and monitored in real time. The Glimpse Protocol platform is currently live on TLE, protecting 1.5million readers so far from their browsing information being obtained by other parties.

In addition to the operational benefits that it provides, it has been agreed that warrants will be issued to Iconic Labs in recognition of their market access and wider advisory support. The warrants entitle Iconic Labs to subscribe for such number of ordinary shares in the capital of Glimpse Protocol, which shall be equal to 1.25% of its issued equity and which are exercisable at a discount to the subscription price payable for ordinary shares on any future sale or capital raise undertaken by Glimpse Protocol.

Glimpse Protocol are a market leader in data protection using frontier technologies. Their cookieless platform uses two forms of advanced cryptography to protect consumers' personal internet browsing data from being seen, read, transferred, sold or recycled by another party.

Google have recently announced within 2 years their chrome browser will no longer be using cookies which store personal browsing data on your PC/Phone. Apple have also taken a similar approach with their safari browser.

Samuel Regan Asante COO of Iconic Labs - "We are very pleased to announce a partnership with Glimpse Protocol who are leading the way in cookie-less technologies within the AdTech industry. Iconic Labs is aiming to establish itself as a leader in both the tech and media fields and Glimpse Protocol's technology presents the perfect balance of the two. With Glimpse Protocol's existing partnership with The Founder's Factory we're excited about their future as a leader in the industry."

 

 

 

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

**ENDS**

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

Damon Heath

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9950

Iconic Labs ir@iconiclabs.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRUKONRROUKUAR
Date   Source Headline
1st May 20194:35 pmRNSPrice Monitoring Extension
1st May 20194:05 pmRNSCorporate Update
1st May 20194:00 pmRNSFinancing Agreement
29th Apr 20192:15 pmRNSHolding(s) in Company
29th Apr 201911:07 amRNSSecond Price Monitoring Extn
29th Apr 201911:00 amRNSPrice Monitoring Extension
29th Apr 201910:38 amRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS 
29th Apr 201910:29 amRNSConversion of Loan Notes & Issue of Shares
29th Apr 201910:14 amRNSTR1 Align Research
26th Apr 201911:05 amRNSHolding(s) in Company
26th Apr 201911:00 amRNSHolding(s) in Company
25th Apr 201910:30 amRNSUpdate on Option
23rd Apr 201911:30 amRNSHolding(s) in Company
17th Apr 201910:05 amRNSHolding(s) in Company
17th Apr 201910:00 amRNSHolding(s) in Company
16th Apr 201912:45 pmRNSHolding(s) in Company
12th Apr 201911:35 amRNSDirector's Interest
12th Apr 201911:30 amRNSHolding(s) in Company
8th Apr 201910:10 amRNSHolding(s) in Company
5th Apr 201912:15 pmRNSHolding(s) in Company
5th Apr 201912:10 pmRNSHolding(s) in Company
3rd Apr 20195:37 pmRNSHolding(s) in Company
2nd Apr 201910:15 amRNSUpdate
21st Mar 20195:02 pmRNSHolding(s) in Company
21st Mar 20195:01 pmRNSUpdate
21st Mar 20195:00 pmRNSHolding(s) in Company
21st Mar 20197:00 amRNSOne2One Investor Forum
19th Mar 20191:42 pmRNSHolding(s) in Company
19th Mar 20191:41 pmRNSHolding(s) in Company
18th Mar 20192:05 pmRNSSecond Price Monitoring Extn
18th Mar 20192:00 pmRNSPrice Monitoring Extension
18th Mar 201911:45 amRNSHolding(s) in Company
18th Mar 20199:05 amRNSSecond Price Monitoring Extn
18th Mar 20199:00 amRNSPrice Monitoring Extension
18th Mar 20197:00 amRNSNew Media Business Created
14th Mar 201910:47 amRNSHolding(s) in Company
14th Mar 201910:46 amRNSUpdate
14th Mar 201910:45 amRNSHolding(s) in Company
12th Mar 20197:00 amRNSHolding(s) in Company
11th Mar 20198:48 amRNSHolding(s) in Company
8th Mar 20194:48 pmRNSHolding(s) in Company
8th Mar 20194:47 pmRNSUpdate
8th Mar 20194:46 pmRNSHolding(s) in Company
8th Mar 20194:45 pmRNSHolding(s) in Company
7th Mar 20192:05 pmRNSSecond Price Monitoring Extn
7th Mar 20192:00 pmRNSPrice Monitoring Extension
7th Mar 201911:00 amRNSPrice Monitoring Extension
6th Mar 20194:03 pmRNSUpdate
6th Mar 20192:00 pmRNSPrice Monitoring Extension
5th Mar 201911:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.